MedTrace Logo

Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease

NCT03414580 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-09-03

No results posted yet for this study

Summary

The availability of noninvasive biomarkers for diagnosis and stratification of inflammatory bowel disease (IBD) courses is lacking. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis on diagnosis and stratification of patients with inflammatory bowel disease.

Conditions

Interventions

PROCEDURE

Breath sampling for volatile organic compounds

Acquisition of exhaled breath sample in exhaled air to be analysed by gas chromatography-mass spectrometry

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Yoo Jin Lee, Professor · Keimyung University Dongsan Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03414580 on ClinicalTrials.gov